BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31758680)

  • 21. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
    Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
    J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of weighted gene co‑expression network analysis to explore the potential diagnostic biomarkers for colorectal cancer.
    Qin L; Zeng J; Shi N; Chen L; Wang L
    Mol Med Rep; 2020 Jun; 21(6):2533-2543. PubMed ID: 32323816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of potential prognostic biomarkers for breast cancer using WGCNA and PPI integrated techniques.
    Zheng G; Zhang C; Zhong C
    Ann Diagn Pathol; 2021 Feb; 50():151675. PubMed ID: 33291061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of breast cancer prognostic modules via differential module selection based on weighted gene Co-expression network analysis.
    Guo L; Mao L; Lu W; Yang J
    Biosystems; 2021 Jan; 199():104317. PubMed ID: 33279569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-efficient Screening Method for Identification of Key Genes in Breast Cancer Through Microarray and Bioinformatics.
    Liu Z; Liang G; Tan L; Su AN; Jiang W; Gong C
    Anticancer Res; 2017 Aug; 37(8):4329-4335. PubMed ID: 28739725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the potential novel biomarkers as susceptibility gene for Wilms tumor.
    Liu L; Song Z; Gao XD; Chen X; Wu XB; Wang M; Hong YD
    BMC Cancer; 2021 Mar; 21(1):316. PubMed ID: 33765954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.
    Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C
    Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of a co‑expression network for the analysis of aggressive and non‑aggressive breast cancer cell lines to predict the clinical outcome of patients.
    Guo L; Zhang K; Bing Z
    Mol Med Rep; 2017 Dec; 16(6):7967-7978. PubMed ID: 28944917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel key genes in triple-negative breast cancer identified by weighted gene co-expression network analysis.
    Chen J; Qian X; He Y; Han X; Pan Y
    J Cell Biochem; 2019 Oct; 120(10):16900-16912. PubMed ID: 31081967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of Weighted Gene Coexpression Network Analysis to Identify Key Modules and Hub Genes in Systemic Juvenile Idiopathic Arthritis.
    Zhou M; Guo R; Wang YF; Yang W; Li R; Lu L
    Biomed Res Int; 2021; 2021():9957569. PubMed ID: 34435051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of location-specific hub genes related to the pathogenesis of colon cancer.
    Shi C; Ding K; Li KZ; Long L; Li JL; Hu BL
    Med Oncol; 2020 Aug; 37(9):77. PubMed ID: 32743717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
    Liu H; Ye H
    Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of
    Yang H; Wang Y; Zhang Z; Li H
    Front Genet; 2020; 11():905. PubMed ID: 32973873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of key molecular targets that correlate with breast cancer through bioinformatic methods.
    Tang W; Guo X; Niu L; Song D; Han B; Zhang H
    J Gene Med; 2020 Mar; 22(3):e3141. PubMed ID: 31697007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weighted gene co-expression network analysis reveals modules and hub genes associated with the development of breast cancer.
    Qiu J; Du Z; Wang Y; Zhou Y; Zhang Y; Xie Y; Lv Q
    Medicine (Baltimore); 2019 Feb; 98(6):e14345. PubMed ID: 30732163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identifying the hub genes in non-small cell lung cancer by integrated bioinformatics methods and analyzing the prognostic values.
    Wang T; Chen X; Jing F; Li Z; Tan H; Luo Y; Shi H
    Pathol Res Pract; 2021 Dec; 228():153654. PubMed ID: 34749208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
    Wu J; Zhang Y; Li M
    J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
    Zhang J; Wu Y; Jin HY; Guo S; Dong Z; Zheng ZC; Wang Y; Zhao Y
    World J Gastroenterol; 2018 Nov; 24(43):4906-4919. PubMed ID: 30487700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Weighted gene correlation network analysis identifies RSAD2, HERC5, and CCL8 as prognostic candidates for breast cancer.
    Tang J; Yang Q; Cui Q; Zhang D; Kong D; Liao X; Ren J; Gong Y; Wu G
    J Cell Physiol; 2020 Jan; 235(1):394-407. PubMed ID: 31225658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.